Primary Menu

Coronavirus Information Center

Nevada’s COVID-19 immunization program is telling health care providers to resume use of the Johnson & Johnson vaccine now that the federal government has lifted an 11-day pause following a safety review of rare but serious reactions. The state issued its guidance Friday after scientific advisers to the federal Centers for Disease Control and Prevention said the benefits of the one-dose J&J shot outweigh a rare risk of blood clots. The federal Food and Drug Administration and the Centers for Disease Control and Prevention earlier this month had jointly recommended a pause in the use of the vaccine.